Judy Brennan

Judy Brennan is a seasoned medical science liaison with extensive experience in oncology and immunology. Currently serving as the Principal Medical Science Liaison at Gilead Sciences since May 2021, Judy Brennan focuses on oncology and immunology. Previously, Judy Brennan held the position of Oncology Senior Director Medical Science Liaison at Epizyme from July 2019 to May 2021, where responsibilities included leading MSL efforts for scientific congresses, establishing credible relationships with key opinion leaders, and providing clinical and scientific information. Prior to that role, Judy Brennan worked as a Medical Science Liaison at Partner Therapeutics from April 2018 to July 2019, contributing to the introduction of a new oncology product and fostering relationships with healthcare practitioners.